우리나라 성인의 허혈성 심장질환, 뇌졸중으로 인한 총 진료비 중 과체중 및 비만의 기여분
Medical Expenditure Attributable to Overweight and Obesity in Adults with Ischemic Heart Disease and Stroke in Korea
2
조회
0
다운로드
10
인용
0
참고문헌
키워드
초록
objectives: This study was conducted to estimate medical expenditure attributable to overweight and obesity in adults with ischemic heart disease and stroke using Korea National Health and Nutrition Examination survey data and Korea National Health Corporation data. methods : The medical expenditure of ischemic heart disease and stroke related to overweight and obesity were composed of inpatient care costs, outpatient care costs and medication costs. The population attributable risk (PAR) of overweight and obesity was calculated from national representative data of Korea such as the National Health Insurance Corporation cohort data and 2005 Korea National Health and Nutrition Examination survey data. results: The medical expenditure attributable to overweight and obesity of ischemic heart disease were 97.4 billion won(74.1-122 billion won). and stroke were 64.6 billion won(33.1-98.1 billion won). Consequently, these costs corresponded to 11.4% of total medical expenditure due to ischemic heart disease and stroke. conclusions: We conclude that overweight and obesity have increased medical expenditure from ischemic heart disease and stroke in Korea. These findings provide important support for implementing overweight and obesity management strategies in Korea.
Abstract
objectives: This study was conducted to estimate medical expenditure attributable to overweight and obesity in adults with ischemic heart disease and stroke using Korea National Health and Nutrition Examination survey data and Korea National Health Corporation data. methods : The medical expenditure of ischemic heart disease and stroke related to overweight and obesity were composed of inpatient care costs, outpatient care costs and medication costs. The population attributable risk (PAR) of overweight and obesity was calculated from national representative data of Korea such as the National Health Insurance Corporation cohort data and 2005 Korea National Health and Nutrition Examination survey data. results: The medical expenditure attributable to overweight and obesity of ischemic heart disease were 97.4 billion won(74.1-122 billion won). and stroke were 64.6 billion won(33.1-98.1 billion won). Consequently, these costs corresponded to 11.4% of total medical expenditure due to ischemic heart disease and stroke. conclusions: We conclude that overweight and obesity have increased medical expenditure from ischemic heart disease and stroke in Korea. These findings provide important support for implementing overweight and obesity management strategies in Korea.
참고문헌 (21)
- 강재헌, "성인의 고혈압, 당뇨병, 이상지질혈증으로 인한 총 진료비 중 과체중 및 비만의 기여분 : 국민건강영양조사자료와 국민건강보험공단 자료를 중심으로", 농촌의학.지역보건, 35(1), pp.77~88 (2010), 한국농촌의학.지역보건학회
- 김남순, "한국인의 비만도에 따른 비만관련질환의 유병률 증가", 예방의학회지, 34(4), pp.309~315 (2001)
- 보건복지부, "2010년 권역심뇌혈관질환센터 설치 및 운영 사업안내" (2010), 보건복지부
- 정백근, "한국인 성인 비만의 사회경제적 비용", 예방의학회지, 35(1), pp.1~12 (2002), 대한예방의학회
- 통계청, "2009년 사망원인 통계결과" (2010), 통계청
- Allison DB, "The direct health care costs of obesity in the United States", AJPH, 89, pp.1194~1199 (1999)
- Anis AH, "Obesity and overweight in Canada: an updated cost-of-illness study", Obes Rev, 11, pp.31~40 (2010)
- Birmingham CL, "The cost of obesity in Canada", CMAJ, 160, pp.483~488 (1999)
- Bonow RO, "World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic", Circulation, 106, pp.1602~1605 (2002)
- Colditz GA, "Economic costs of obesity and inactivity", Med Sci Sports Exerc, 31, pp.S663~S667 (1999)
- Dixon JB, "The effect of obesity on health outcomes", Mol Cell Endocrinol, 316, pp.104~108 (2010)
- Fu T, "Costs of metabolic syndrome - related diseases induced by obesity in Taiwan", Obes Rev, 9(1), pp.68~73 (2008)
- Reaven GM, "Pathophysiology of insulin resistance in human disease", Physiol Rev, 75, pp.473~486 (1995)
- Sturm R, "Increasing obesity rates and disability trends", Health Affair, 23, pp.168~176 (2004)
- Swinburn B, "Health care costs of obesity in New Zealand", Int J Obes Relat Metab Disord, 21(10), pp.891~896 (1997)
- Thompson D, "Body mass index and future healthcare costs: a retrospective cohort study", Obes Res, 9, pp.210~218 (2001)
- Wang, "Economic burden of cardiovascular disease associated with excess body weight in U.S. adults", Am J Prev Med, 23(1), pp.1~6 (2002)
- Willi C, "Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis", JAMA, 298, pp.2654~2664 (2007)
- Wolf AM, "Current estimates of the economic cost of obesity in the United States", Obes Res, 6, pp.97~106 (1998)
- Yusuf S, "Effect of potentially modifiable risk factors associated with myocardial infarction in 52countries (the INTERHEART study): case-control study", Lancet, 364, pp.937~952 (2004)
- Zhao W, "Economic burden of obesity-related chronic diseases in Mainland China", Obes Rev, 9, pp.S62~S67 (2008)